103P First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
Autor: | Andric, Z.G., Gálffy, G., Dols, M. Cobo, Szima, B., Stojanovic, G., Petrovic, M.D., Font, E. Felip, Baz, D. Vicente, Aix, S. Ponce, Juan-Vidal, O., Tehenes, S., Szalai, Z., Losonczy, G., Blanco, A. Calles, Bernabe, R., Duecker, K., Zhou, D., Schroeder, A., Guezel, G., Ciardiello, F. |
---|---|
Zdroj: | In Journal of Thoracic Oncology April 2021 16(4) Supplement:S753-S754 |
Databáze: | ScienceDirect |
Externí odkaz: |